12-101764223-CTTT-CTTTT
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_024312.5(GNPTAB):c.2693dupA(p.Tyr899ValfsTer21) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000372 in 1,613,724 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_024312.5 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNPTAB | NM_024312.5 | c.2693dupA | p.Tyr899ValfsTer21 | frameshift_variant | Exon 13 of 21 | ENST00000299314.12 | NP_077288.2 | |
GNPTAB | XM_011538731.3 | c.2612dupA | p.Tyr872ValfsTer21 | frameshift_variant | Exon 13 of 21 | XP_011537033.1 | ||
GNPTAB | XM_006719593.4 | c.2693dupA | p.Tyr899ValfsTer21 | frameshift_variant | Exon 13 of 19 | XP_006719656.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152056Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461668Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 727150
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152056Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74296
ClinVar
Submissions by phenotype
Pseudo-Hurler polydystrophy;C2673377:Mucolipidosis type II Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 39057). This premature translational stop signal has been observed in individual(s) with mucolipidosis II (PMID: 19617216). This variant is present in population databases (rs281864999, gnomAD 0.0008%). This sequence change creates a premature translational stop signal (p.Tyr899Valfs*21) in the GNPTAB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GNPTAB are known to be pathogenic (PMID: 19617216, 25107912). -
Mucolipidosis Pathogenic:1
Variant summary: GNPTAB c.2693dupA (p.Tyr899ValfsX21) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 250934 control chromosomes. c.2693dupA has been reported in the literature in individuals affected with Mucolipidosis and subsequently cited by others (example, Cathey_2010, Wang_2018, Velho_2019 and Yu_2019). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. -
Mucolipidosis type II Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at